This qualitative study characterizes the perspectives of patients with cancer regarding their experience with prior authorization for cancer care.

Welcome to ‘Cancer Clear and Simple,’ the podcast dedicated to simplifying cancer. Join us as we discuss the world of cancer, breaking down complex concepts for our listening audience. One of our goal...

Nearly half of cancer patients and survivors in the United States face medical debt so crushing that it has sparked a relatively new focus within oncology: financial toxicity. To access this subscribe...

It’s great to start by celebrating still being alive at the end of another year given that, in May 2017, I was told I might only live 2 years! 2024 saw me enter my 8th year post diagnosis having su…

YouTube video by GU Cast

The Ohio Department of Medicaid department in 2022 gave powerful prescription drug middlemen the boot and created a new system. The result: Fees paid to pharmacies were boosted more than 1,200% while ...

The reduction in force comes along with a reorganization of the Department of Health and Human Services, consolidating 28 divisions to 15.

Cuts will affect the Food and Drug Administration, Centers for Disease Control and Prevention, and the National Institutes of Health

Kuzuoglu-Ozturk et al. showcase a therapeutic approach, “translatome therapy,” to combat lethal prostate cancer. Zotatifin, a clinical molecule, targets the RNA-helicase eIF4A. Zotatifin decreases the select translation of key oncogenes, androgen receptor (AR), and HIF1α through remodeling their 5′ UTR RNA structure. Zotatifin enhances anti-androgen and radiotherapy sensitivity, highlighting a promising anti-cancer treatment.

Background Data on the safety profiles and clinical outcomes of patients with solid tumors and cardiac metastasis treated with immune checkpoint inhibitors (ICIs) are limited. Methods This is an inte...

Harrison, whose plasma contained a rare antibody, rolled up his sleeve 1,173 times from 1954 to 2018. The Australian is credited with helping 2.4 million babies and advancing scientific research.

The Androgen Receptor (AR) is a ligand-dependent transcription factor that drives prostate cancer development and progression. Although, a detailed effect on AR biology has been described for a number...

Policy follows firings of tenure-track scientists and suspension of training programs

What happens when a team of scientists and local Awajún guides go on a 38-day trip into the Alto Mayo region of Peru? Over 2000 species are identified, of course! Tucked in this lush landscape where…